NWR communications sat down recently with Hashan De Silva, CFA , Founder and Managing Partner of new specialist healthcare fund KP Rx on our Vantage Point podcast. Hashan talked about how his investment process has an edge in the life sciences sector, why now is the right time to invest, and the diverse experience he brings to funds management.He also talked about his success in being an early investor in Neuren Pharmaceuticals Limited and how having a specialist advisory board fitting to each potential investment helped him stay the course even through its meteoric performance. Listen/watch on:Apple Podcasts: https://lnkd.in/gZJtfaJiSpotify: https://lnkd.in/gb6gQ-nvYouTube: https://lnkd.in/gKmPR_kP
NEU Price at posting:
$20.78 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)